New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 24, 2012
16:00 EDTNVS, BAC, MSFT, AAPLOptions Update; February 24, 2012
CBOE Volatility Index-VIX up .51 to 17.31. Option volume leaders today: NVS BAC MSFT AAPL according to Track Data.
News For NVS;BAC;MSFT;AAPL From The Last 14 Days
Check below for free stories on NVS;BAC;MSFT;AAPL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
April 8, 2014
06:24 EDTAAPLApple may develop baseband chpis for iPhones inhouse, DigiTimes says
Subscribe for More Information
06:20 EDTAAPLApple may release iWatch in Q3, DigiTimes reports
Subscribe for More Information
06:07 EDTMSFT, AAPLMicrosoft investing in 'invisible user interface' technology, WSJ reports
Subscribe for More Information
06:01 EDTMSFTMicrosoft ending support for Windows XP today, AP reports
Subscribe for More Information
05:45 EDTMSFTNokia, Microsoft receive approval from China for Devices & Services transaction
Subscribe for More Information
April 7, 2014
19:57 EDTBACFederal Reserve announces extension on some CLOs
The Federal Reserve Board announced that it intends to exercise its authority to give banking entities two additional one-year extensions to conform their ownership interests in and sponsorship of certain collateralized loan obligations, or CLOs, covered by section 619 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, commonly referred to as the Volcker rule. Section 619 of the Dodd-Frank Act directed the board to adopt rules for the conformance period and the board previously extended the conformance period for all activities and investments by one year to July 21, 2015. To ensure effective compliance, the board intends to grant banking entities two additional one-year extensions, which together would extend until July 21, 2017, to conform their ownership interests in and sponsorship of CLOs to the statute. Publicly traded companies that may be impacted by the announcement include Bank of America (BAC), Citigroup (C), Goldman Sachs (GS), JPMorgan (JPM), Morgan Stanley (MS), U.S. Bancorp (USB) and Wells Fargo (WFC). Reference Link
16:01 EDTAAPLOptions Update; April 7, 2014
Subscribe for More Information
14:06 EDTAAPLApple slips to lows of the day, levels to watch
Shares were last at $522.56, just off the session low. At current price, next support is at $517.35. Resistance is at $527.67.
10:10 EDTMSFTAnalyst sees 'golden' opportunity after software stocks decline
Subscribe for More Information
09:34 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:00 EDTMSFTMicrosoft May volatility increases; shares near 14-year high into Q3
Microsoft April weekly call option implied volatility is at 29, April is at 23, May is at 25, July is at 21; compared to its 26-week average of 23 according to Track Data, suggesting large near term price movement into the expected release of Q3 results on April 24.
08:45 EDTAAPLInvenSense price target raised to $27 from $20 at Pacific Crest
Subscribe for More Information
07:51 EDTAAPLApple sent iTV panel samples from Korean display maker, Korea Herald says
Subscribe for More Information
07:37 EDTAAPLApple considered dumping long-time ad agency, WSJ reports
Subscribe for More Information
07:27 EDTNVSAmerican Association of Cancer Research to hold annual meeting
Subscribe for More Information
07:16 EDTAAPLRetailers muscle into competitive mobile payment market, Reuters says
Subscribe for More Information
06:41 EDTMSFTMicrosoft pushes for programming to rival Amazon, Netflix, Bloomberg says
Subscribe for More Information
06:36 EDTAAPLApple's sales force worried about iPhone outlook, Re/code reports
Apple's (AAPL) sales force has been worried about weakness in the iPhone's market share, amid strong competition from Google's (GOOG) Android operating system, a document presented in a court case showed, Re/code reported on Friday. According to the internal Apple document, the only portions of the smartphone market showing growth were large devices costing more than $300 or devices that cost less than $300, the website stated. Reference Link
06:18 EDTMSFTMicrosoft starts developing 4th-generation Surface, DigiTimes reports
Subscribe for More Information
05:32 EDTNVSNovartis Bexsero vaccine receives FDA Breakthrough Therapy designation
Novartis announced that Bexsero, Meningococcal Group B Vaccine, has received a Breakthrough Therapy designation from the FDA. Bexsero is already approved in Europe, Canada and Australia to help protect against invasive meningococcal disease caused by serogroup B. Novartis plans to file for U.S. licensure of Bexsero as early as Q2; exact timing will depend on guidance from the FDA. This is the fourth Breakthrough Therapy designation for Novartis, underscoring leadership in developing innovative therapies and vaccines. This announcement comes on the heels of a landmark decision from regulators in the UK, where the Joint Committee on Vaccination and Immunisation recommended the inclusion of Bexsero in the country's National Immunisation Programme for routine use in infants from two months of age.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use